News

Arthex Biotech es una spin-off de la Universidad de Valencia que está desarrollando tratamientos avanzados con RNA contra enfermedades genéticas. Nuestro equipo tiene una gran experiencia en el descubrimiento de fármacos y en el estudio de los mecanismos de patogénesis de enfermedades neuromusculares. Nuestro principal objetivo es encontrar tratamientos efectivos para necesidades médicas insatisfechas. El … Read more

Arthex Biotech is a spin-off of the University of Valencia, developing advanced treatments with RNA against genetic diseases. Our team has extensive experience in drug discovery and the study of the pathogenesis mechanisms of neuromuscular diseases.  Arthex’s goal is to find effective treatments for unmet medical needs. The company is fully focused on developing treatment … Read more

Con motivo del Día Internacional de Concienciación sobre la Distrofia Miotónica o enfermedad de Steinert, el 15 de Septiembre, queremos acercarnos más a los pacientes y conocerlos mejor.  Es un día de reconocimiento a esta enfermedad y a quienes la padecen. Es un momento emocionante para la comunidad ya que es una oportunidad para compartir … Read more

On the occasion of the International Day of Awareness on Myotonic Dystrophy or Steinert’s disease, on September 15, we want to get closer to patients and get to know them better. It is a day of recognition of this disease and those who suffer from it. It is an exciting time for the community as … Read more

We are delighted to announce a new addition to our growing team, Sheila Soriano. In 2019, she graduated in Chemistry from the University of Zaragoza, where she specialized in Analytical Sciences, oriented towards research and innovation, both from a chemical and biological point of view. In 2018, during her Erasmus studies in Italy, she had the … Read more